INTRODUCTION
============

The cells that form the human body originate from stem cells; among the different types of adult stem cells, those from the bone marrow are the most extensively studied. Bone-marrow derived mesenchymal stem cells (hBMSCs) that are present in the bone marrow can differentiate into hematopoietic stem cells, osteoblasts, chondrocytes, endothelial cells, and adipocytes ([@b4-molce-38-7-663]; [@b9-molce-38-7-663]; [@b31-molce-38-7-663]; [@b39-molce-38-7-663]). hBMSCs not only support hematopoietic stem cell differentiation but also differentiate into chondrocytes, osteocytes, or adipocytes under appropriate experimental conditions ([@b32-molce-38-7-663]). hBMSCs also promote the bone marrow engraftment of transplanted hematopoietic stem cells. Therefore, hBMSCs have been widely applied in tissue engineering for their multipotency. Cotransplantation of MSCs has been attempted for hematopoietic stem cell transplantation ([@b42-molce-38-7-663]). They have been injected at bone fracture sites as a part of bone regeneration therapy. In addition, MSCs or endothelial cells have been co-cultured for studies in biocompatibility and angiogenesis ([@b7-molce-38-7-663]).

Biocompatible and biodegradable scaffolds have been widely investigated in tissue engineering and regenerative medicine to serve as a substrate for cells or a physical support to guide the formation of new extracellular metrix (ECM) ([@b3-molce-38-7-663]; [@b25-molce-38-7-663]; [@b30-molce-38-7-663]). Currently, a variety of biomaterial scaffolds, including artificial scaffolds made from hydroxyapatite/tricalcium phosphate or a combination of both ([@b6-molce-38-7-663]; [@b24-molce-38-7-663]; [@b37-molce-38-7-663]) and biodegradable polymer scaffolds ([@b16-molce-38-7-663]; [@b20-molce-38-7-663]) have been prepared for tissue engineering applications and investigated in terms of biocompatibility and tissue regeneration capacities. Synthetic biodegradable polymer scaffolds may have versatile physico-chemical properties such as mechanical and degradation properties, which can be easily modulated to generate appropriate functional properties in the body. Therefore, many polymer scaffolds have been used as a substrate for tissue regeneration, providing mechanical and structural support during tissue development ([@b25-molce-38-7-663]).

Ideal scaffolds should be able to fuse with the natural cellular matrix and degrade at a rate commensurate with the elucidation of new ECM by the seeded cells. Thus, the biodegradability of the scaffold is an important criterion for biological tissue and material selection. PCL, one of the representative biodegradable polyesters, has been broadly studied as a biomaterial due to its good biocompatibility. Cell survival significantly increased when PCL was introduced in the body as a thin layer ([@b10-molce-38-7-663]). Our previous study showed that poly(ethylene glycol) (PEG) and poly(ε-caprolactone) (PCL) based hydrogels could be useful for applications and tissue engineering due to several promising properties, such as elasticity, biodegradability, good biocompatibility, and tailor-made physico-chemical properties ([@b13-molce-38-7-663]; [@b27-molce-38-7-663]). In addition, the hydrogels could offer a suitable environment for cell retention and growth.

Recently, biodegradable polymer scaffolds for inducing angiogenesis have attracted much attention as replacement materials for injured or atrophied tissues since they were successfully used to culture stem cells for transplantation ([@b15-molce-38-7-663]; [@b28-molce-38-7-663]; [@b36-molce-38-7-663]; [@b40-molce-38-7-663]; [@b41-molce-38-7-663]). Angiogenesis, the formation of new capillaries from pre-existing blood vessels, is the primary mechanism for vascularization of tissue engineering ([@b25-molce-38-7-663]). The structure and properties of polymer scaffolds play an important role in regulating tissue growth and angiogenesis. The angiogenesis can be promoted by introducing growth factors such as VEGF, IGF, EGF, PDGF, and TGF-β ([@b29-molce-38-7-663]; [@b34-molce-38-7-663]; [@b35-molce-38-7-663]). It was also reported that angiogenesis was enhanced when Matrigel was used together with polymer scaffolds ([@b19-molce-38-7-663]). Matrigel exists in the liquid forms at 4°C but forms gels at 37°C, which allows it to easily penetrate and coat the porous polymer scaffold ([@b18-molce-38-7-663]).

In this study, biodegradable elastic hydrogels consisting of hydrophilic PEG and hydrophobic PCL blocks were evaluated as a tissue engineering scaffold for angiogenesis. We hypothesized that the biodegradable hydrogel scaffold is suitable for supporting and growing hBMSCs, controlling the release of VEGF, and finally effectively inducing angiogenesis.

MATERIALS AND METHODS
=====================

Materials
---------

Polycaprolactone diol (PCL diol, Mn = 1250 or 2000), benzene (anhydrous grade), acryloyl chloride, triethylamine, dimethyl sulfoxide (DMSO, anhydrous grade), and PEG diacrylate (PEG-DA, Mn = 700) were purchased from Sigma-Aldrich. 2,2′-azobisisobutyronitrile (AIBN) was obtained from JUNSEI Chemicals (Japan) and used after purification by recrystallization in methanol. Sodium chloride powder (size distribution: 180--400 μm, 99%) was purchased from Samchun Pure Chemicals. The other chemicals were of reagent grade, and were used as received.

Preparation of PEG/PCL hydrogel scaffolds
-----------------------------------------

The hydrogel scaffolds were prepared according to the same method as that previously reported ([@b27-molce-38-7-663]). The predetermined amounts of diacrylated PCL (PCL-DA) and PEG-DA were dissolved in 5 ml of DMSO and placed into polypropylene conical tubes containing 7 g of sodium chloride salt particulates (size distribution: 180--400 μm, 99%). The feed ratio between PCL-DA and PEG-DA was varied from 14:6 to 6:14 by weight, but the total polymer concentration was fixed at 20 wt.%. After radical crosslinking reaction with a small amount of AIBN at 70°C for 12 h, the resultant hydrogel was cut into discs with thicknesses of 3 mm and immersed in distilled water and then ethyl alcohol to remove residual salt and chemicals. Finally, the scaffold was washed with distilled water several times and freeze-dried for 2--3 days.

Isolation and culture of hBMSCs
-------------------------------

The hBMSCs were isolated and cultured as described in previous works ([@b1-molce-38-7-663]; [@b11-molce-38-7-663]). The hBMSCs were maintained in an IMDM with 10% FBS, L-glutamine, penicillin (100 units/ml), and streptomycin (100 μg/ml) at 37°C, in a 95%O2/5% CO~2~ incubator. The hBMSCs were characterized using a mesenchymal stem cell kit (Chemicon, USA).

Assessment of cell viability (MTT assay)
----------------------------------------

Cell viability was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay (Sigma, USA). hBMSCs were seeded in 96-well plates at 5 × 10^3^ cells/well and incubated for both 48 h and 8 days. The MTT assay was performed according to the manufacturer's instructions. DMSO (Sigma, USA) was used to dissolve the formazan crystals for 2h at room temperature, and optical density was measured at 570 nm using a microplate reader.

Assay of VEGF secretion
-----------------------

The 0.1 pg of VEGF (10 μg/ml, 10 μl) was applied on dried porous PEG:PCL(6:14) pieces and placed at the center of a 48-well plate. 100 μl of VEGF reduced Matrigel was applied at the top of the scaffolds carefully allowing the scaffolds were completely coated. The scaffolds were incubated in a 37°C incubator for 20 min for complete gelation of Matrigel. 600 μl of phosphate buffer solution (PBS) was added, of which 50 μl of it was removed at 30, 60, 90, 120, 150, 180, and 210 min to determine the VEGF release. The determination of VEGF concentration was carried out with VEGF detection ELISA kit (R&D systems).

Implantation of hydrogel scaffolds in BALB/c mice
-------------------------------------------------

Scaffolds with a diameter of 3 mm (with and without hBMSC, with and without Matrigel coating) were surgically transplanted under the skin of the lateral groins of 6 week old BALB/c nude mice. After 1 to 4 weeks, the mice were sacrificed in CO~2~ chamber and the transplants were excised and subjected to immunohistochemistry.

Immunohistochemistry
--------------------

Samples were fixed in 10% formaldehyde and paraffinized. The samples were cut into 5 mm of thickness and then incubated at 60°C for 1 h. The slides were deparaffinized and used antigen retrieval technique for promoting sensitivity of tissue staining.

The sections were washed and then incubated in 3% hydrogen peroxide for 6 min. The sections were blocked for 1h and stained with primary anti-CD31 antibody (1:20 dilution, rabbit polyclonal, AbCam, UK) for 30 min, and then washed three times with Tris buffered saline (TBST) with Triton X-100. The sections were incubated in secondary HRP-conjugated anti-rabbit anti-body as per the manufacturer's recommendation. After washing, the sections were counterstained with hematoxylin and then mounted with permount solution.

RESULTS
=======

Preparation of PEG/PCL hydrogel scaffolds
-----------------------------------------

Three types of porous hydrogel scaffolds with different block compositions (PEG:PCL = 6:14 or 14:6 by weight, PCL block (MW = 1250 or 2000) were fabricated using the salt leaching method. The polymer composition could be easily modulated by varying the feed ratio of the PEG and PCL block components to demonstrate different hydrophilicity. By using the salt leaching process, a highly porous structure could be introduced in the hydrogel samples. The characterization for chemical and physical properties of the hydrogels was performed and described in detail in our previous report ([@b13-molce-38-7-663]; [@b27-molce-38-7-663]).

Determination of the identity of hBMSCs
---------------------------------------

To determine the identity of human bone-marrow derived MSCs, we performed immunofluorescence staining for their specific markers such as collagen type I, fibronectin, CD54, Integrin1β, and Hu ([Fig. 1](#f1-molce-38-7-663){ref-type="fig"}). We observed that the isolated stem cells stained positively in the cytoplasm and the nucleus for the presence of MSC marker proteins they did not show the presence of CD14, a representative marker for hematopoietic stem cells; thus, we were able to confirm that the hBMSCs were not contaminated with hematopoietic stem cells (HSCs) ([Fig. 1](#f1-molce-38-7-663){ref-type="fig"}).

Cytotoxicity of the scaffold in MSCs and growth tests
-----------------------------------------------------

To determine which type of scaffold is suitable for development of MSCs, we cultured MSCs on three different hydrogel scaffolds, and performed the assessment of cell death by MTT assay with 3 × 10^5^ of the initial cells and at two different cell culture times of 2 days and 8 days. The MSCs grew on all scaffolds, and the highest growth rate was observed for the hydrogel scaffold of PEG/PCL = 6/14 and PCL block of MW = 1250 ([Fig. 2](#f2-molce-38-7-663){ref-type="fig"}). Therefore all the subsequent experiments were thus performed with the hydrogel scaffold.

Morphological studies on biodegradable hydrogel scaffold
--------------------------------------------------------

To assess the biodegradability of the porous polymer scaffolds, we studied morphological aspects both in vitro ([Figs. 3A and 3B](#f3-molce-38-7-663){ref-type="fig"}) and *in vivo* ([Figs. 3C--3E](#f3-molce-38-7-663){ref-type="fig"}). It was clearly observed that the biodegradation proceeded in significantly different patterns between *in vitro* and *in vivo*. The scanning electron microscope (SEM) images from the hydrogel samples with degradation time of 2 days and 10 weeks *in vitro* did not show any significant morphological change. On the other hand, in *in vivo*, the shape of the angular parts of the pores and the corners of the material at 4 weeks ([Fig. 3E](#f3-molce-38-7-663){ref-type="fig"}) was significantly different from the shape at 2 weeks ([Fig. 3D](#f3-molce-38-7-663){ref-type="fig"}). When the hydrogel scaffold was transplanted in the BALB/c mouse to determine the biodegradability, more than 50% of the scaffold material degraded after 4 weeks ([Fig. 3E](#f3-molce-38-7-663){ref-type="fig"}).

Regulation of VEGF secretion using Matrigel coating on scaffold
---------------------------------------------------------------

Porous scaffolds may be useful for drug loading and delivery for tissue engineering, especially peptide hormones. However, the peptide hormone quickly diffuses out through their porous structure, making it difficult to achieve the desired function. Recently, various efforts have been made to control the release of growth hormones in scaffolds transplanted with cells by introducing functional groups to the biodegradable polymers used for cell transplantation ([@b12-molce-38-7-663]). Here, we aimed to control the release of VEGF by coating the scaffold containing VEGF with Matrigel. The release of VEGF from the porous scaffold was saturated within 30 min and did not change thereafter. When the scaffold was coated with Matrigel, the VEGF was able to be released in a controlled way for more than 210 min ([Fig. 4](#f4-molce-38-7-663){ref-type="fig"}). It indicated that the introduction of Matrigel coating on the hydrogel scaffold may allow the controlled release and prolonged functionality of VEGF.

Angiogenesis by regulating VEGF release
---------------------------------------

In order to assess the angiogenic effects of VEGF and Matrigel coating, various hydrogel scaffolds prepared with and without VEGF loading and Matrigel coating were subcutaneously implanted in BALB/c mice and immunohistochemistry for the presence of CD31 was performed after 1 week or 4 weeks. One week after implantation, the CD31 staining patterns were observed to be similar between the Matrigel coated samples and the Matrigel coated samples with VEGF ([Fig. 5](#f5-molce-38-7-663){ref-type="fig"}). In the case of the Matrigel coated samples with VEGF loading, infiltration by unknown cells showed a significant increase. Four weeks after implantation, significantly more angiogenesis was observed in the Matrigel coated scaffold with VEGF loading than in the other samples. The CD31 positive cells (vasculature) were frequently present inside the scaffold ([Fig. 6](#f6-molce-38-7-663){ref-type="fig"}).

DISCUSSION
==========

This study showed that the Matrigel coated PEG/PCL hydrogel scaffold could demonstrate the controlled release of VEGF *in vitro*, and promoted the angiogenesis when transplanted in BALB/c mice.

When stem cells are transplanted to treat diseases, porous polymer scaffolds are used to control stem cell growth, to maximize the effect in the treated area, and minimize excessive growth of the transplanted cells in other areas or to control differentiation ([@b17-molce-38-7-663]; [@b21-molce-38-7-663]). The most popular polymer scaffold materials are poly(glycolic acid) (PGA), PEG, PCL, and their copolymers ([@b2-molce-38-7-663]; [@b5-molce-38-7-663]; [@b8-molce-38-7-663]; [@b22-molce-38-7-663]; [@b33-molce-38-7-663]). The biodegradability of these materials depends on the microenvironment of the transplantation, and should be evaluated case by case depending on the treatment method. Previous study have reported that the PEG/PCL hydrogels did not show significant degradation in water up to 50 days; further, when the PEG content was increased to PEG:PCL= 4:1, degradation was observed to begin from 3 months and to accelerate after 5 months ([@b27-molce-38-7-663]). The biocompatibility of these scaffolds also depends on the type of cells to be transplanted and the combination of materials. It has been shown in our previous study that the hydrogel scaffold with PEG:PCL=14:6 resulted in the best cell growth for chondrocytes ([@b27-molce-38-7-663]).

The physical properties of cell transplantation polymer scaffolds, such as hardness and strength, are important factors to be considered depending on the purpose of treatment. For example, for the healing of the femur, which supports the body weight, the cutting plane receives a high stress, the healing time is long, and the material should not degrade for 8--12 weeks. Therefore, metal is therefore often used, and during regeneration, the cut surface movement is suppressed and traditional surgery is used. Cell transplantation material for this purpose has not been commercialized yet. In contrast, for cranial injuries, where the body weight is not applied, biodegradable polymer scaffolds can be used, which can biodegrade before bone regeneration ([@b24-molce-38-7-663]; [@b37-molce-38-7-663]). Our *in vivo* results showed that the PEG/PCL hydrogel scaffold degraded by more than 50% after 4 weeks. When the scaffold was implanted in the body after 1 week, more than 5 cells were observed per 150 μm pore diameter, and the biodegradability was probably accelerated by these cells.

The matrigel is the most commonly used material in determining angiogenesis by physiologically active substances. Matrigel is not synthesized, but is purified from the basement membrane of an Engelbreth-Holm-Swarm tumor and contains various physiologically active substances ([@b18-molce-38-7-663]). Both growth factor containing Matrigel (GFCM) and growth factor reduced Matrigel (GFRM) are available from the manufacturer. Matrigel exists as a liquid at a low temperature range of 0--20°C, but becomes a gel at a temperature above 30°C. This unique temperature-sensitive property makes it useful for introducing physiologically active substances and cells by simple mixing in a solution state and preventing migration by temperature-induced gelation. Especially, GFRM, where almost all VEGF is removed, is a great material to assess substances for angiogenesis because it does not have any angiogenic potential in itself ([@b14-molce-38-7-663]; [@b23-molce-38-7-663]; [@b26-molce-38-7-663]). When stem cells adhere to polymer scaffolds for transplantation, it is difficult to engraft the stem cells in the middle of the scaffold ([@b15-molce-38-7-663]; [@b21-molce-38-7-663]; [@b28-molce-38-7-663]; [@b36-molce-38-7-663]). Furthermore, timely angiogenesis is an important objective to achieve in stem cell transplantation, and many studies are being conducted to achieve this ([@b7-molce-38-7-663]; [@b15-molce-38-7-663]; [@b23-molce-38-7-663]; [@b38-molce-38-7-663]; [@b40-molce-38-7-663]). When VEGF is simply applied to polymer scaffolds for angiogenesis, because of fast diffusion, the VEGF gradient disappears and appropriate angiogenesis cannot occur ([@b15-molce-38-7-663]). Therefore, we aimed to control the release of VEGF by Matrigel coating and to maintain the VEGF concentration gradient. Our results demonstrated that the release of VEGF from the porous scaffold without Matrigel coating reached the maximum within 30 min. On the other hand, the Matrigel coated scaffold released the VEGF in a controlled pattern for more than 210 min ([Fig. 4](#f4-molce-38-7-663){ref-type="fig"}).
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![Characterization of mesenchymal stem cells from human bone marrow. Cells were stained for specific mesenchymal stem cell markers with corresponding antibodies and analyzed using a confocal microscope (× 600). Positive markers: Integrin B, collagen type I, fibronectin, CD-54. Negative markers: CD-45, CD-14. Culture media: IMDM/20% FBS, 2 mM Glutamine (passage 3). The right figures of two upper lanes are merge of left two figures.](molce-38-7-663f1){#f1-molce-38-7-663}

![Viability of hBMSC on the plate type PEG:PCL scaffolds. (A) Cells were seeded on three kinds of PEG:PCL plate type scaffolds and incubated for 2 days or 8 days. Cell viability was determined by MTT assay. (B) Low (left) and high (right) magnification of hBMSCs on PEG:PCL (6:14) scaffolds after 2 days of culture were examined using H&E staining.](molce-38-7-663f2){#f2-molce-38-7-663}

![Biodegradation rates of porous PEG:PCL polymer *in vitro* and *in vivo*. (A, B) After incubating in IMDM with 10% FBS for 2 days and 10 weeks, scaffolds were analyzed using SEM (× 500). (B--E) Scaffolds were transplanted into the back flank of BALB/c nude mice subcutaneously for 1, 2, 4 weeks. Removed scaffolds were examined under a light microscope (× 400).](molce-38-7-663f3){#f3-molce-38-7-663}

![Influence of Matrigel coating on the release of VEGF from porous PEG:PCL(6:14) scaffolds. Porous scaffolds scaffolds containing VEGF was coated with Matrigel were placed in PBS. Released VEGF was assayed by ELISA.](molce-38-7-663f4){#f4-molce-38-7-663}

![Cell recruitment at early phase of transplantation by Matrigel-coated scaffolds containing VEGF. Combinatorial scaffolds were implanted into the back flank of BLAB/c nude mice subcutaneously. Immunohistochemistry analysis against CD-31 was performed after 1 week. (A) Scaffolds only, (B) Matrigel coated scaffolds, (C) Scaffolds with VEGF, and (D) VEGF containing scaffolds coated by Matrigel.](molce-38-7-663f5){#f5-molce-38-7-663}

![Angiogenic effects of Matrigel-coated scaffolds containing VEGF. Combinatorial scaffolds were implanted into the back flank of BLAB/c nude mice subcutaneously. Immunohistochemistry analysis against CD-31 was performed after 4 weeks. (A) Scaffolds only, (B) Matrigel coated scaffolds, (C) Scaffolds with VEGF, and (D) VEGF containing scaffolds coated with Matrigel. (E) Statistic analysis for CD-31 positive vessels (^\*^*p* \< 0.05).](molce-38-7-663f6){#f6-molce-38-7-663}
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